simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 14;5^{th}-Individual ID 14;5^{th}-Individual ID 14;5^{th}-Individual ID 14;5^{th}-Individual ID 14;;;95^{th}-Individual ID 21;95^{th}-Individual ID 21;95^{th}-Individual ID 21;95^{th}-Individual ID 21;95^{th}-Individual ID 21
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;0.303214462616726;-0.241193076021116;0.107237451523465;0.406654845605978;-0.957754610811967;;;0.140466273501008;-0.0382091956727107;0.0189255520356104;0.116735276513547;-0.274582323544646
;0.287407699024689;-0.280693691195369;0.107202104542253;0.405366012138811;-1.06580388119275;;;-7.97509160936658;-8.15974179862409;-8.10662839497066;-8.00818674289159;-8.38569456658633
;0.319021226208763;-0.201692460846864;0.107272798504677;0.407943679073145;-0.849705340431187;;;8.2560241563686;8.08332340727867;8.14447949904188;8.24165729591869;7.83652991949704
;0.999195667312457;0.992117927444127;0.999999967818168;0.999997024640143;0.996244220611687;;;0.0010103440055762;7.47185217506718e-05;1.83140382845615e-05;0.000696408708268481;0.00385396931741022
;9.68383251035195e-06;0.000297700514065499;2.45021959176042e-12;2.17820374539352e-09;9.7797785274932e-05;;;0.959535739788333;0.98899427021304;0.994551200193224;0.966403673032788;0.921007649991182
